Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir + Ribavirin +/- PEG in Chronic HCV
NCT01260350Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Dec 2010; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01260350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260350.